enprofylline has been researched along with Aging in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muraoka, I | 1 |
| Hasegawa, T | 1 |
| Nadai, M | 1 |
| Wang, L | 1 |
| Tagaya, O | 1 |
| Nabeshima, T | 1 |
1 other study available for enprofylline and Aging
| Article | Year |
|---|---|
Influence of age on the disposition and renal handling of enprofylline in rats.
Topics: Aging; Animals; Blood Proteins; Bronchodilator Agents; Kidney; Male; Protein Binding; Rats; Rats, In | 1994 |